Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • 言語
  • クリニックポータル
  • お問い合わせはこちらへ
  • お問い合わせはこちらへ
  • Part of brands: |
アイジェノミクス・ジャパンアイジェノミクス・ジャパン
  • Part of brands: |
  • 患者様向け
    • EndomeTRIO検査
    • ERA検査
    • EMMA検査
    • ALICE検査
    • PGT-A検査
    • POC検査
    • PGT-M検査
    • CGT検査
  • 医療関係者向け
    • EndomeTRIO検査
    • ERA検査
    • EMMA検査
    • ALICE検査
    • PGT-A検査
    • POC検査
    • PGT-M検査
    • CGT検査
    • NACE(NIPT)検査
  • ニュース・ブログ
  • Academy
Home > Genetic Solutions

Igenomix Research & Foundation

Providing solutions for professionals working in reproductive medicine

  • Overview
  • Projects
  • Patents
  • Publications
  • Foundation

+ 350 scientific publications

+ 6 patents

Collaborative projects with internationally renowned centers

17 laboratories worldwide

Overview
  • Research
  • Advanced Technology
  • Innovation
  • Development

Research

The basis of our products lies in research intended to fulfill the needs of professionals and their patients.
All the research projects performed at Igenomix are intended for clinical use.
IGENOMIX actively works in research and has organized and participated in many national and international talks and conferences.
The result of this hard work has led to the publication of a large number of peer reviewed articles.

Advanced Technology

We use the most advanced techniques through our continuous collaboration with high profile researchers, universities and companies.
We rely on the translational research experience acquired by Prof. Carlos Simón (2011 Jaime I award-winner for Clinical Research), who led the IVI Foundation until 2016.
We have acquired broad clinical experience through our wide network of institutes specialized in reproductive medicine around the world.

Innovation

Today’s advances in knowledge will lead to more comprehensive and convenient diagnostic systems to be used by patients in the future.
IGENOMIX makes a financial contribution to research, development and innovation to offer both medical professionals and patients a wide range of products and services meeting all their expectations.

Development

At IGENOMIX, we work to develop all phases of designing diagnostic tests. From the original concept, undertaking clinical studies, producing and analyzing results, to creating products that can be commercialized, Igenomix is committed to developing each test to be backed with scientific evidence.
In the Products Development Department, we do not merely adapt already established procedures, but we innovate to provide our patients with the best services.

Projects
  • Brochure for your patients

BROCHURE

Technical Brochure

Download
Patents

Relevant related studies:

Rubio et al

In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study.

Fertil Steril. 2017 May;107(5):1122-1129.

Read
Rubio et al

Preimplantation Genetic Testing for Aneuploidies using fluorescence in situ hybridization inpatients with repetitive implantation failure and advanced maternal age: two randomized trials.

Fertil Steril. 2013 Apr;99(5):1400-7.

Read
Yang Z, Liu J, Collins GS, Salem SA, Liu X, Lyle SS, et al.

Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study.

Mol Cytogenet 2012 May 2; 5(1):24.

Read
Coates A, Kung A, Mounts E, Hesla J, Bankowski B, Barbieri E, Ata B, Cohen J, Munné S.

Optimal euploid embryo transfer strategy, fresh versus frozen, after Preimplantation Genetic Testing for Aneuploidies with next generation sequencing: a randomized controlled trial.

Fertil Steril. 2017 Mar;107(3):723-730.e3.

Read
Coates A, Bankowski BJ, Kung A, Griffin DK, Munne S.

Differences in pregnancy outcomes in donor egg frozen embryo transfer (FET) cycles following Preimplantation Genetic Testing for Aneuploidies (PGT-A): a single center retrospective study.

J Assist Reprod Genet. 2017 Jan;34(1):71-78.

Read

If you´re a little lost with this technical information...

Can we help you?

I’m not a health specialist

パンフレット

ダウンロード
email

Subscribe to
our newsletter

[gravityform id=1 title=false description=false ajax=true tabindex=49]

アイジェノミクスのメディア掲載情報

患者様向け

検査案内
お悩みの患者様

医療関係者様向け

検査案内
ウェブセミナー&説明会

企業情報

アイジェノミクスについて
グローバル拠点
ニュース・コラム
採用情報

株式会社 アイジェノミクス・ジャパン

〒103-0013
東京都中央区日本橋人形町2-7-10
エル人形町4F

土日祝日休業、営業時間:9時~18時

03-6667-0456
お問い合わせはこちらへ

Igenomix Japan, K.K.

L Ningyocho 4F, 2-7-10 Nihonbashi Ningyocho,
Chuo-ku, Tokyo 103-0013

+81-3-6667-0456

  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
言語

[2021] © Igenomix プライバシーポリシークッキーポリシー ソーシャルメディアポリシー

お問い合わせ


  • reCAPTCHA demo: Simple page

  • 患者様向け
    • EndomeTRIO検査
    • ERA検査
    • EMMA検査
    • ALICE検査
    • PGT-A検査
    • POC検査
    • PGT-M検査
    • CGT検査
  • 医療関係者向け
    • EndomeTRIO検査
    • ERA検査
    • EMMA検査
    • ALICE検査
    • PGT-A検査
    • POC検査
    • PGT-M検査
    • CGT検査
    • NACE(NIPT)検査
  • ニュース・ブログ
  • Academy
  • 言語
  • クリニックポータル